- Home
- PMT vs MLTX Comparison
PMT vs MLTX Comparison
Compare PMT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- MLTX
- Stock Information
- Founded
- PMT 2009
- MLTX 2021
- Country
- PMT United States
- MLTX Switzerland
- Employees
- PMT N/A
- MLTX N/A
- Industry
- PMT Real Estate Investment Trusts
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- MLTX Health Care
- Exchange
- PMT Nasdaq
- MLTX Nasdaq
- Market Cap
- PMT 1.1B
- MLTX 904.7M
- IPO Year
- PMT 2009
- MLTX N/A
- Fundamental
- Price
- PMT $12.43
- MLTX $12.73
- Analyst Decision
- PMT Hold
- MLTX Buy
- Analyst Count
- PMT 5
- MLTX 9
- Target Price
- PMT $14.13
- MLTX $36.78
- AVG Volume (30 Days)
- PMT 909.9K
- MLTX 2.4M
- Earning Date
- PMT 10-21-2025
- MLTX 11-05-2025
- Dividend Yield
- PMT 12.84%
- MLTX N/A
- EPS Growth
- PMT N/A
- MLTX N/A
- EPS
- PMT 0.92
- MLTX N/A
- Revenue
- PMT $564,655,000.00
- MLTX N/A
- Revenue This Year
- PMT N/A
- MLTX N/A
- Revenue Next Year
- PMT $29.90
- MLTX N/A
- P/E Ratio
- PMT $13.59
- MLTX N/A
- Revenue Growth
- PMT N/A
- MLTX N/A
- 52 Week Low
- PMT $11.60
- MLTX $5.95
- 52 Week High
- PMT $14.93
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- PMT 56.22
- MLTX 44.10
- Support Level
- PMT $12.00
- MLTX $9.84
- Resistance Level
- PMT $12.28
- MLTX $13.07
- Average True Range (ATR)
- PMT 0.23
- MLTX 0.68
- MACD
- PMT 0.03
- MLTX 1.41
- Stochastic Oscillator
- PMT 65.64
- MLTX 90.53
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.